These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1726202)
21. A comparison of cefpodoxime proxetil and cefaclor in the treatment of acute exacerbation of COPD in adults. Phillips H; Van Hook CJ; Butler T; Todd WM Chest; 1993 Nov; 104(5):1387-92. PubMed ID: 8222793 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of cefpodoxime proxetil and interactions with an antacid and an H2 receptor antagonist. Saathoff N; Lode H; Neider K; Depperman KM; Borner K; Koeppe P Antimicrob Agents Chemother; 1992 Apr; 36(4):796-800. PubMed ID: 1354432 [TBL] [Abstract][Full Text] [Related]
23. Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group. Asmar BI; Dajani AS; Del Beccaro MA; Mendelman PM Pediatrics; 1994 Dec; 94(6 Pt 1):847-52. PubMed ID: 7971000 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of cefpodoxime proxetil dry syrup in pediatric patients with various infections. Muranaka H; Yokoyama M J Chemother; 1995 Nov; 7 Suppl 4():127-30. PubMed ID: 8904132 [No Abstract] [Full Text] [Related]
25. Bioavailability of cefpodoxime proxetil with co-administered acetylcysteine. Kees F; Wellenhofer M; Bröhl K; Grobecker H Arzneimittelforschung; 1996 Apr; 46(4):435-8. PubMed ID: 8740095 [TBL] [Abstract][Full Text] [Related]
26. [Observational study of the tolerance and effectiveness of cefpodoxim-proxetil in general practice]. Hanke K; Blum SP Fortschr Med Orig; 2002; 120(1):21-8. PubMed ID: 14518354 [TBL] [Abstract][Full Text] [Related]
27. A multi-institutional study on clinical effectiveness of cefpodoxime proxetil dry syrup in childhood infections. Imanaka H; Kitahara T; Yoshinaga M; Miyata K J Chemother; 1995 Nov; 7 Suppl 4():131-3. PubMed ID: 8904133 [No Abstract] [Full Text] [Related]
28. Clinical evaluation of cefpodoxime proxetil in patients with dermatological infections. Imaizumi T; Ishikawa H; Hashimoto I J Chemother; 1995 Nov; 7 Suppl 4():137-41. PubMed ID: 8904135 [No Abstract] [Full Text] [Related]
29. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Portier H; Chavanet P; Waldner-Combernoux A; Kisterman JP; Grey PC; Ichou F; Safran C Scand J Infect Dis; 1994; 26(1):59-66. PubMed ID: 8191242 [TBL] [Abstract][Full Text] [Related]
31. Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients. Ito K; Ito M J Chemother; 1995 Nov; 7 Suppl 4():124-6. PubMed ID: 8904131 [No Abstract] [Full Text] [Related]
32. A review of the pharmacokinetics of cefpodoxime proxetil. Borin MT Drugs; 1991; 42 Suppl 3():13-21. PubMed ID: 1726203 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of infectious complications affecting the skin and soft tissues with cefpodoxime proxetil]. Vyhnánek F; Lochmann O Epidemiol Mikrobiol Imunol; 1996 May; 45(2):68-70. PubMed ID: 8756403 [TBL] [Abstract][Full Text] [Related]